| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10.494 | 24.508 | 20.194 | 38.236 | 37.938 | 45.491 | 44.481 |
| Total Income - EUR | - | - | - | 10.494 | 24.508 | 20.289 | 38.300 | 37.938 | 45.491 | 44.485 |
| Total Expenses - EUR | - | - | - | 4.459 | 17.871 | 16.623 | 19.317 | 19.879 | 15.581 | 21.000 |
| Gross Profit/Loss - EUR | - | - | - | 6.035 | 6.638 | 3.666 | 18.983 | 18.059 | 29.910 | 23.485 |
| Net Profit/Loss - EUR | - | - | - | 5.880 | 6.393 | 3.497 | 18.608 | 17.736 | 29.532 | 22.310 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Butnaru Alexandra S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 35.002 | 28.604 | 22.905 | 5.701 | 0 | 0 | 731 |
| Current Assets | - | - | - | 3.252 | 3.110 | 2.590 | 14.649 | 23.240 | 30.538 | 22.650 |
| Inventories | - | - | - | 0 | 0 | 145 | 142 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.496 | 2.844 | 2.060 | 1.870 | 2.392 | 21.275 | 11.221 |
| Cash | - | - | - | 1.757 | 266 | 386 | 12.638 | 20.847 | 9.263 | 11.428 |
| Shareholders Funds | - | - | - | 5.923 | 7.565 | 6.370 | 19.580 | 22.436 | 29.580 | 22.372 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 32.332 | 24.149 | 19.125 | 770 | 804 | 957 | 1.008 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Butnaru Alexandra S.r.l.